Sermo, a healthcare data collection company and social platform for physicians, is conducting a weekly survey among physicians globally. The current results are for the second wave of the survey, conducted March 30-April 2. Physicians could select more than one option.
Of the 1,662 physicians who reported treating COVID-19 patients, half said they used azithromycin or similar antibiotics; 44 percent said they used hydroxychloroquine or chloroquine; and 36 percent said they used bronchodilators.
The physicians who reported treating COVID-19 patients also said that certain over-the-counter medications have been effective, including acetaminophen (42 percent) and cold medications, such antihistamines, decongestants and cough medications (29 percent).
More articles on patient outcomes:
5 US coronavirus patients begin treatment using blood from recovered patients
Why UPMC’s care rationing framework is gaining popularity among hospitals
COVID-19 kills 13% of people over age 80, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
